Influence of depression symptoms on serum tumor necrosis factor-α of patients with chronic low back pain

Arthritis Research and Therapy

Volumn 12, Issue 5, 2010, Pages

  Wang, Haili ^a   Ahrens, Carsten ^a   Rief, Winfried ^b   Gantz, Simone ^a   Schiltenwolf, Marcus ^a   Richter, Wiltrud ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; NARCOTIC ANALGESIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CHRONIC PAIN; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEPRESSION; FEMALE; HAMILTON SCALE; HUMAN; LOW BACK PAIN; MALE; NORMAL HUMAN; PAIN ASSESSMENT; QUESTIONNAIRE; SLEEP TIME; SMOKING HABIT; VISUAL ANALOG SCALE; BLOOD; CHRONIC DISEASE; COMORBIDITY; CROSS-SECTIONAL STUDY; MIDDLE AGED; PSYCHOLOGICAL ASPECT;

ADULT; AGED; CHRONIC DISEASE; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HUMANS; LOW BACK PAIN; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 77957674680     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3156     Document Type: Article

References (75)

1. Bair MJ, Wu J, Damush TM, Sutherland JM, Kroenke K. Association of depression and anxiety alone and in combination with chronic musculoskeletal pain in primary care patients. Psychosom Med 2008, 70:890-897. 10.1097/PSY.0b013e318185c510, 2902727, 18799425.
2. Ericsson M, Poston WS, Linder J, Taylor JE, Haddock CK, Foreyt JP. Depression predicts disability in long-term chronic pain patients. Disabil Rehabil 2002, 24:334-340. 10.1080/09638280110096241, 12017467.
3. Sheehan DV. Establishing the real cost of depression. Manag Care 2002, 11:7-10. discussion 21-25.
4. Greenberg PE, Birnbaum HG. The economic burden of depression in the US: societal and patient perspectives. Expert Opin Pharmacother 2005, 6:369-376. 10.1517/14656566.6.3.369, 15794728.
5. Airaksinen E, Wahlin A, Larsson M, Forsell Y. Cognitive and social functioning in recovery from depression: results from a population-based three-year follow-up. J Affect Disord 2006, 96:107-110. 10.1016/j.jad.2006.05.004, 16782205.
6. Pfingsten M, Schöps P. Low back pain: from symptom to chronic disease. Z Orthop Ihre Grenzgeb 2004, 142:146-152. 10.1055/s-2004-822622, 15106058.
7. Poleshuck EL, Bair MJ, Kroenke K, Damush TM, Tu W, Wu J, Krebs EE, Giles DE. Psychosocial stress and anxiety in musculoskeletal pain patients with and without depression. Gen Hosp Psychiatry 2009, 31:116-122. 10.1016/j.genhosppsych.2008.10.003, 2677657, 19269531.
8. Schiltenwolf M. Assessment of musculoskeletal pain. Z Rheumatol 2007, 66:473-483. 10.1007/s00393-007-0205-1, 17849126.
9. Murray JB. Psychophysiological aspects of motion sickness. Percept Mot Skills 1997, 85:1163-1167.
10. Mullington J, Korth C, Hermann DM, Orth A, Galanos C, Holsboer F, Pollmächer T. Dose-dependent effects of endotoxin on human sleep. Am J Physiol Regul Integr Comp Physiol 2000, 278:R947-R955.
11. Maier SF, Wiertelak EP, Martin D, Watkins LR. Interleukin-1 mediates the behavioral hyperalgesia produced by lithium chloride and endotoxin. Brain Res 1993, 623:321-324. 10.1016/0006-8993(93)91446-Y, 8221116.
12. Dantzer R, Kelley KW. Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun 2007, 21:153-160. 10.1016/j.bbi.2006.09.006, 1850954, 17088043.
13. Kelley KW, Bluthé RM, Dantzer R, Zhou JH, Shen WH, Johnson RW, Broussard SR. Cytokine-induced sickness behavior. Brain Behav Immun 2003, 17(Suppl 1):S112-S118. 10.1016/S0889-1591(02)00077-6, 12615196.
14. Anisman H, Hayley S, Turrin N, Merali Z. Cytokines as a stressor: implications for depressive illness. Int J Neuropsychopharmacol 2002, 5:357-373. 10.1017/S1461145702003097, 12466035.
15. Anisman H, Kokkinidis L, Merali Z. Further evidence for the depressive effects of cytokines: anhedonia and neurochemical changes. Brain Behav Immun 2002, 16:544-556. 10.1016/S0889-1591(02)00011-9, 12401468.
16. Anisman H, McIntyre DC. Conceptual, spatial, and cue learning in the Morris water maze in fast or slow kindling rats: attention deficit comorbidity. J Neurosci 2002, 22:7809-7817.
17. Anisman H, Merali Z. Cytokines, stress, and depressive illness. Brain Behav Immun 2002, 16:513-524. 10.1016/S0889-1591(02)00009-0, 12401465.
18. Anisman H, Merali Z, Hayley S. Sensitization associated with stressors and cytokine treatments. Brain Behav Immun 2003, 17:86-93. 10.1016/S0889-1591(02)00100-9, 12676571.
19. Anisman H, Merali Z. Cytokines, stress and depressive illness: brain-immune interactions. Ann Med 2003, 35:2-11. 10.1080/07853890310004075, 12693607.
20. Strouse TB. The relationship between cytokines and pain/depression: a review and current status. Curr Pain Headache Rep 2007, 11:98-103. 10.1007/s11916-007-0005-y, 17367587.
21. Wang H, Schiltenwolf M, Buchner M. The role of TNF-α in patients with chronic low back pain-a prospective comparative longitudinal study. Clin J Pain 2008, 24:273-278. 10.1097/AJP.0b013e31816111d3, 18287835.
22. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957, 16:494-502. 10.1136/ard.16.4.494, 1006995, 13498604.
23. Roland M, Morris R. A study of the natural history of back pain. Part I: development of a reliable and sensitive measure of disability in low-back pain. Spine (Phila Pa 1976) 1983, 8:141-144.
24. Hautzinger M, Bailer M. Allgemeine Depressionsskala 1993, Weinheim: Beltz.
25. Cunha FQ, Poole S, Lorenzetti BB, Ferreira SH. The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol 1992, 107:660-664. 1907751, 1472964.
26. Junger H, Sorkin LS. Nociceptive and inflammatory effects of subcutaneous TNFα. Pain 2000, 85:145-151. 10.1016/S0304-3959(99)00262-6, 10692613.
27. Cuellar JM, Montesano PX, Carstens E. Role of TNF-α in sensitization of nociceptive dorsal horn neurons induced by application of nucleus pulposus to L5 dorsal root ganglion in rats. Pain 2004, 110:578-587. 10.1016/j.pain.2004.03.029, 15288398.
28. Okamoto K, Martin DP, Schmelzer JD, Mitsui Y, Low PA. Pro- and anti-inflammatory cytokine gene expression in rat sciatic nerve chronic constriction injury model of neuropathic pain. Exp Neurol 2001, 169:386-391. 10.1006/exnr.2001.7677, 11358451.
29. Schäfers M, Geis C, Svensson CI, Luo ZD, Sommer C. Selective increase of tumour necrosis factor-alpha in injured and spared myelinated primary afferents after chronic constrictive injury of rat sciatic nerve. Eur J Neurosci 2003, 17:791-804. 10.1046/j.1460-9568.2003.02504.x, 12603269.
30. Schäfers M, Sorkin LS, Geis C, Shubayev VI. Spinal nerve ligation induces transient upregulation of tumor necrosis factor receptors 1 and 2 in injured and adjacent uninjured dorsal root ganglia in the rat. Neurosci Lett 2003, 347:179-182. 10.1016/S0304-3940(03)00695-5, 12875915.
31. Schäfers M, Svensson CI, Sommer C, Sorkin LS. Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J Neurosci 2003, 23:2517-2521.
32. Sommer C, Schmidt C, George A. Hyperalgesia in experimental neuropathy is dependent on the TNF receptor 1. Exp Neurol 1998, 151:138-142. 10.1006/exnr.1998.6797, 9582261.
33. Sommer C, Schäfers M, Marziniak M, Toyka KV. Etanercept reduces hyperalgesia in experimental painful neuropathy. J Peripher Nerv Syst 2001, 6:67-72. 10.1046/j.1529-8027.2001.01010.x, 11446385.
34. Koch A, Zacharowski K, Boehm O, Stevens M, Lipfert P, von Giesen HJ, Wolf A, Freynhagen R. Nitric oxide and pro-inflammatory cytokines correlate with pain intensity in chronic pain patients. Inflamm Res 2007, 56:32-37. 10.1007/s00011-007-6088-4, 17334668.
35. Uçeyler N, Rogausch JP, Toyka KV, Sommer C. Differential expression of cytokines in painful and painless neuropathies. Neurology 2007, 69:42-49. 10.1212/01.wnl.0000265062.92340.a5, 17606879.
36. Uçeyler N, Eberle T, Rolke R, Birklein F, Sommer C. Differential expression patterns of cytokines in complex regional pain syndrome. Pain 2007, 132:195-205. 10.1016/j.pain.2007.07.031, 17890011.
37. Uçeyler N, Tscharke A, Sommer C. Early cytokine expression in mouse sciatic nerve after chronic constriction nerve injury depends on calpain. Brain Behav Immun 2007, 21:553-560. 10.1016/j.bbi.2006.10.003, 17204395.
38. Wang H, Moser M, Schiltenwolf M, Buchner M. Circulating cytokine levels compared to pain in patients with fibromyalgia - a prospective longitudinal study over 6 months. J Rheumatol 2008, 35:1366-1370.
39. Wallace DJ, Linker-Israeli M, Hallegua D, Silverman S, Silver D, Weisman MH. Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study. Rheumatology (Oxford) 2001, 40:743-749. 10.1093/rheumatology/40.7.743, 11477278.
40. Tuglu C, Kara SH, Caliyurt O, Vardar E, Abay E. Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology (Berl) 2003, 170:429-433. 10.1007/s00213-003-1566-z, 12955291.
41. Huang TL, Lee CT. T-helper 1/T-helper 2 cytokine imbalance and clinical phenotypes of acute-phase major depression. Psychiatry Clin Neurosci 2007, 61:415-420. 10.1111/j.1440-1819.2007.01686.x, 17610667.
42. Dantzer R, Wollman E, Vitkovic L, Yirmiya R. Cytokines and depression: fortuitous or causative association?. Mol Psychiatry 1999, 4:328-332. 10.1038/sj.mp.4000572, 10483048.
43. Dantzer R, Wollman EE, Vitkovic L, Yirmiya R. Cytokines, stress and depression. Conclusions and perspectives. Cytokines, Stress, and Depression: Advances in Experimental Medicine and Biology 1999, 317-329. New York: Kluwer Academic/Plenum, Dantzer R, Wollman EE, Yirmiya R.
44. Kronfol Z. Cytokine regulation in major depression. Cytokines and Mental Health 2003, 259-280. Boston: Kluwer Academic, Kronfol Z.
45. Suarez EC, Lewis JG, Kuhn C. The relation of aggression, hostility, and anger to lipopolysaccharide-stimulated tumor necrosis factor (TNF)-alpha by blood monocytes from normal men. Brain Behav Immun 2002, 16:675-684. 10.1016/S0889-1591(02)00019-3, 12480498.
46. Herbert TB, Cohen S. Stress and immunity in humans: a meta-analytic review. Psychosom Med 1993, 55:364-379.
47. Herbert TB, Cohen S. Depression and immunity: a meta-analytic review. Psychol Bull 1993, 113:472-486. 10.1037/0033-2909.113.3.472, 8316610.
48. Dunn AJ. Cytokines, stress, and depression. Cytokines, Stress and Immunity 2007, 193-214. Boca Raton, FL: Taylor & Francis/CRC Press, Plotnikoff N, 2.
49. Segerstrom SC, Miller GE. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull 2004, 130:601-630. 10.1037/0033-2909.130.4.601, 1361287, 15250815.
50. Irwin M, Lacher U, Caldwell C. Depression and reduced natural killer cytotoxicity: a longitudinal study of depressed patients and control subjects. Psychol Med 1992, 22:1045-1050. 10.1017/S0033291700038617, 1488477.
51. Beaurepaire RD. Neuroimmune mediators: are cytokines mediators of depression?. Biology of Depression, from Novel Insights to Therapeutic Strategies 2005, 557-581. Weinheim: Wiley-VCH, Licinio J, Wong ML.
52. Murali R, Hanson MD, Chen E. Psychological stress and its relationship to cytokines and inflammatory diseases. Cytokines, Stress and Immunity 2007, 29-49. Boca Raton, FL: Taylor & Francis/CRC Press, Plotnikoff N, 2.
53. Słuzewska A, Rybakowski JK, Laciak M, Mackiewicz A, Sobieska M, Wiktorowicz K. Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann N Y Acad Sci 1995, 762:474-476. 10.1111/j.1749-6632.1995.tb32372.x, 7668562.
54. Kronfol Z. Behavioural effects of cytokines: a psychiatrist's perspective. Cytokines, Stress and Immunity 2007, 1-16. Boca Raton, FL: Taylor & Francis/CRC Press, Plotnikoff N, 2.
55. Kubera M, Symbirtsev A, Basta-Kaim A, Borycz J, Roman A, Papp M, Claesson M. Effect of chronic treatment with imipramine on interleukin 1 and interleukin 2 production by splenocytes obtained from rats subjected to a chronic mild stress model of depression. Pol J Pharmacol 1996, 48:503-506.
56. Robinson MJ, Edwards SE, Iyengar S, Bymaster F, Clark M, Katon W. Depression and pain. Front Biosci 2009, 14:5031-5051.
57. Biver F, Wikler D, Lotstra F, Damhaut P, Goldman S, Mendlewicz J. Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex. Br J Psychiatry 1997, 171:444-448. 10.1192/bjp.171.5.444, 9463603.
58. Frot M, Mauguière F. Dual representation of pain in the operculo-insular cortex in humans. Brain 2003, 126:438-450. 10.1093/brain/awg032, 12538410.
59. Apkarian AV, Bushnell MC, Treede RD, Zubieta JK. Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain 2005, 9:463-484. 10.1016/j.ejpain.2004.11.001, 15979027.
60. Mondal S, Sharma VK, Das S, Goswami U, Gandhi A. Neuro-cognitive functions in patients of major depression. Indian J Physiol Pharmacol 2007, 51:69-75.
61. Alexopoulos GS, Gunning-Dixon FM, Latoussakis V, Kanellopoulos D, Murphy CF. Anterior cingulate dysfunction in geriatric depression. Int J Geriatr Psychiatry 2008, 23:347-355. 10.1002/gps.1939, 17979214.
62. Honda T, Maruta T, Takahashi K. Brain perfusion abnormality in patients with chronic pain. Keio J Med 2007, 56:48-52. 10.2302/kjm.56.48, 17609588.
63. Bingel U, Quante M, Knab R, Bromm B, Weiller C, Büchel C. Subcortical structures involved in pain processing: evidence from single-trial fMRI. Pain 2002, 99:313-321. 10.1016/S0304-3959(02)00157-4, 12237210.
64. Lange JH. Endotoxin as a factor for joint pain and rheumatoid arthritis. Clin Rheumatol 2004, 23:566. author reply 567, 10.1007/s10067-004-0947-y, 15801083.
65. MacMaster FP, El-Sheikh R, Upadhyaya AR, Nutche J, Rosenberg DR, Keshavan M. Effect of antipsychotics on pituitary gland volume in treatment-naive first-episode schizophrenia: a pilot study. Schizophr Res 2007, 92:207-210. 10.1016/j.schres.2007.01.022, 17337162.
66. Deak T, Bellamy C, D'Agostino LG, Rosanoff M, McElderry NK, Bordner KA. Behavioral responses during the forced swim test are not affected by anti-inflammatory agents or acute illness induced by lipopolysaccharide. Behav Brain Res 2005, 160:125-134. 10.1016/j.bbr.2004.11.024, 15836907.
67. Frank MG, Baratta MV, Sprunger DB, Watkins LR, Maier SF. Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses. Brain Behav Immun 2007, 21:47-59. 10.1016/j.bbi.2006.03.005, 16647243.
68. Glaser R. Stress-associated immune dysregulation and its importance for human health: a personal history of psychoneuroimmunology. Brain Behav Immun 2005, 19:3-11. 10.1016/j.bbi.2004.06.003, 15581732.
69. Glaser R, Robles TF, Sheridan J, Malarkey WB, Kiecolt-Glaser JK. Mild depressive symptoms are associated with amplified and prolonged inflammatory responses after influenza virus vaccination in older adults. Arch Gen Psychiatry 2003, 60:1009-1014. 10.1001/archpsyc.60.10.1009, 14557146.
70. Kiecolt-Glaser JK, Loving TJ, Stowell JR, Malarkey WB, Lemeshow S, Dickinson SL, Glaser R. Hostile marital interactions, proinflammatory cytokine production, and wound healing. Arch Gen Psychiatry 2005, 62:1377-1384. 10.1001/archpsyc.62.12.1377, 16330726.
71. Irwin MR, Olmos L, Wang M, Valladares EM, Motivala SJ, Fong T, Newton T, Butch A, Olmstead R, Cole SW. Cocaine dependence and acute cocaine induce decreases of monocyte proinflammatory cytokine expression across the diurnal period: autonomic mechanisms. J Pharmacol Exp Ther 2007, 320:507-515. 10.1124/jpet.106.112797, 17068203.
72. Pace TW, Hu F, Miller AH. Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav Immun 2007, 21:9-19. 10.1016/j.bbi.2006.08.009, 1820632, 17070667.
73. Raison CL, Miller AH. Depression in cancer: new developments regarding diagnosis and treatment. Biol Psychiatry 2003, 54:283-294. 10.1016/S0006-3223(03)00413-X, 12893104.
74. Watkins LR, Maier SF. The pain of being sick: implications of immune-to-brain communication for understanding pain. Annu Rev Psychol 2000, 51:29-57. 10.1146/annurev.psych.51.1.29, 10751964.
75. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006, 27:24-31. 10.1016/j.it.2005.11.006, 16316783.